Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 170 articles:
HTML format
Text format



Single Articles


    April 2019
  1. BOUGEA A, Maraki MI, Yannakoulia M, Stamelou M, et al
    Higher probability of prodromal Parkinson disease is related to lower cognitive performance.
    Neurology. 2019 Apr 3. pii: WNL.0000000000007453.
    PubMed     Text format     Abstract available


    March 2019
  2. CONNOR KI, Cheng EM, Barry F, Siebens HC, et al
    Randomized trial of care management to improve Parkinson disease care quality.
    Neurology. 2019 Mar 22. pii: WNL.0000000000007324.
    PubMed     Text format     Abstract available


  3. CALABRESI P, Nigro P, Schwarz HB
    A nurse-led model increases quality of care in Parkinson disease.
    Neurology. 2019 Mar 22. pii: WNL.0000000000007295.
    PubMed     Text format    


  4. BUCHMAN AS, Yu L, Wilson RS, Leurgans SE, et al
    Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies.
    Neurology. 2019 Mar 20. pii: WNL.0000000000007315.
    PubMed     Text format     Abstract available


  5. METZER WS, Rodrigues FB
    Managing treatment fluctuations in Parkinson disease: "On" again-, "off" again.
    Neurology. 2019 Mar 1. pii: WNL.0000000000007193.
    PubMed     Text format    


    February 2019
  6. AKHTAR RS, Mano T
    High serum neurofilament light chain predicts a worse fate in early parkinsonism.
    Neurology. 2019 Feb 27. pii: WNL.0000000000007194.
    PubMed     Text format    


  7. MARQUES TM, van Rumund A, Oeckl P, Kuiperij HB, et al
    Serum NFL discriminates Parkinson disease from atypical parkinsonisms.
    Neurology. 2019 Feb 27. pii: WNL.0000000000007179.
    PubMed     Text format     Abstract available


  8. CHUNG SJ, Bae YJ, Jun S, Yoo HS, et al
    Dysautonomia is associated with structural and functional alterations in Parkinson disease.
    Neurology. 2019 Feb 22. pii: WNL.0000000000007181.
    PubMed     Text format     Abstract available


  9. VIDENOVIC A, Messinis L
    Enlightened PD: A novel treatment for Parkinson disease?
    Neurology. 2019 Feb 15. pii: WNL.0000000000007078.
    PubMed     Text format    


  10. RUTTEN S, Vriend C, Smit JH, Berendse HW, et al
    Bright light therapy for depression in Parkinson disease: A randomized controlled trial.
    Neurology. 2019 Feb 15. pii: WNL.0000000000007090.
    PubMed     Text format     Abstract available


  11. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2019;92:329-337.
    PubMed     Text format     Abstract available


  12. CHEN CC
    Is outcome of subthalamic nucleus deep brain stimulation in Parkinson disease predictable?
    Neurology. 2019 Feb 8. pii: WNL.0000000000007023.
    PubMed     Text format    


  13. SCHUEPBACH WMM, Tonder L, Schnitzler A, Krack P, et al
    Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2019 Feb 8. pii: WNL.0000000000007037.
    PubMed     Text format     Abstract available


    December 2018
  14. PRANGE S, Danaila T, Laurencin C, Caire C, et al
    Age and time course of long-term motor and nonmotor complications in Parkinson disease.
    Neurology. 2018 Dec 12. pii: WNL.0000000000006737.
    PubMed     Text format     Abstract available


    November 2018
  15. JUTTUKONDA MR, Franco G, Englot DJ, Lin YC, et al
    White matter differences between essential tremor and Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006694.
    PubMed     Text format     Abstract available


  16. KIM R, Lee J, Kim HJ, Kim A, et al
    CSF beta-amyloid42 and risk of freezing of gait in early Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006692.
    PubMed     Text format     Abstract available


  17. KARCESKI S
    Parkinson disease and mortality: Understanding how the two are connected.
    Neurology. 2018;91:e2106-e2108.
    PubMed     Text format    


  18. KOO BB
    Author response: Demoralization in Parkinson disease.
    Neurology. 2018;91:1030.
    PubMed     Text format    


  19. BRUNO V, Mancini D, Zurowski M, Miyasaki JM, et al
    Reader response: Demoralization in Parkinson disease.
    Neurology. 2018;91:1029.
    PubMed     Text format    


  20. GANESH A, Galetta S
    Editors' note: Demoralization in Parkinson disease.
    Neurology. 2018;91:1029.
    PubMed     Text format    


  21. BLEDSOE IO, Stebbins GT, Merkitch D, Goldman JG, et al
    White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.
    Neurology. 2018 Nov 14. pii: WNL.0000000000006646.
    PubMed     Text format     Abstract available


  22. TURCANO P, Mielke MM, Bower JH, Parisi JE, et al
    Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study.
    Neurology. 2018 Nov 7. pii: WNL.0000000000006643.
    PubMed     Text format     Abstract available


    October 2018
  23. GOLBE LI, Leyton CE
    Life expectancy in Parkinson disease.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006560.
    PubMed     Text format    


  24. BACKSTROM D, Granasen G, Domellof ME, Linder J, et al
    Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006576.
    PubMed     Text format     Abstract available


  25. FERRAYE MU
    Author response: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:811.
    PubMed     Text format    


  26. VAN GERPEN JA, Tipton PW, Uitti RJ
    Reader response: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:810-811.
    PubMed     Text format    


  27. KARAM C, Galetta S
    Editors' note: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:810.
    PubMed     Text format    


  28. HELMICH RC, Hallett M, Dirkx MF
    Author response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:724.
    PubMed     Text format    


  29. JANKOVIC J
    Reader response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:723.
    PubMed     Text format    


  30. KARAM C, Galetta S
    Editors' note: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:722.
    PubMed     Text format    


  31. GERAEDTS VJ, Boon LI, Marinus J, Gouw AA, et al
    Clinical correlates of quantitative EEG in Parkinson disease: A systematic review.
    Neurology. 2018 Oct 5. pii: WNL.0000000000006473.
    PubMed     Text format     Abstract available


    September 2018
  32. MORENO GM, Gandhi R, Lessig SL, Wright B, et al
    Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
    Neurology. 2018 Sep 26. pii: WNL.0000000000006396.
    PubMed     Text format    


    August 2018
  33. SPERLING SA, Shah BB, Barrett MJ, Bond AE, et al
    Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life.
    Neurology. 2018 Aug 29. pii: WNL.0000000000006279.
    PubMed     Text format     Abstract available


  34. ADAMS JL, La Morgia C
    The search for Parkinson disease biomarkers: Retinal thinning as a correlate of dopamine loss.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006148.
    PubMed     Text format    


  35. AHN J, Lee JY, Kim TW, Yoon EJ, et al
    Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006157.
    PubMed     Text format     Abstract available


  36. KLEPITSKAYA O, Liu Y, Sharma S, Sillau SH, et al
    Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006162.
    PubMed     Text format     Abstract available


  37. PAGANO G, De Micco R, Yousaf T, Wilson H, et al
    REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Neurology. 2018 Aug 8. pii: WNL.0000000000006134.
    PubMed     Text format     Abstract available


  38. MACLEOD AD, Myint PK, Counsell CE
    Author response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:287.
    PubMed     Text format    


  39. MARINELLI L
    Reader response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:286.
    PubMed     Text format    


  40. ALCAUSKAS M, Galetta S
    Editors' note: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:286.
    PubMed     Text format    


  41. THOMPSON T, Poulter D, Miles C, Solmi M, et al
    Driving impairment and crash risk in Parkinson disease: A systematic review and meta-analysis.
    Neurology. 2018 Aug 3. pii: WNL.0000000000006132.
    PubMed     Text format     Abstract available


    July 2018
  42. KARCESKI S
    Does deep brain stimulation help early or mild Parkinson disease?
    Neurology. 2018;91:e495-e497.
    PubMed     Text format    


  43. BRODSKY MA
    Author response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:241-242.
    PubMed     Text format    


  44. TROSTER AI
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240-241.
    PubMed     Text format    


  45. AZIZ TZ
    Editorialist response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240.
    PubMed     Text format    


  46. SIDIROPOULOS C
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239-240.
    PubMed     Text format    


  47. KARAM C, Galetta S
    Editors' note: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239.
    PubMed     Text format    


  48. FERRER P
    Author response: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:192.
    PubMed     Text format    


  49. BHATTACHARJEE S
    Reader response: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:191-192.
    PubMed     Text format    


  50. ALCAUSKAS M, Galetta S
    Editors' note: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:191.
    PubMed     Text format    


  51. FIRBANK MJ, Parikh J, Murphy N, Killen A, et al
    Reduced occipital GABA in Parkinson disease with visual hallucinations.
    Neurology. 2018 Jul 18. pii: WNL.0000000000006007.
    PubMed     Text format     Abstract available


  52. ONOFRJ M, Gilbert GJ
    GABA and hallucinations in Parkinson disease: Who is that sitting on my chair?
    Neurology. 2018 Jul 18. pii: WNL.0000000000005985.
    PubMed     Text format    


  53. SEARLES NIELSEN S, Racette BA
    Author response: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:104.
    PubMed     Text format    


  54. KAWADA T
    Reader response: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:104.
    PubMed     Text format    


  55. ALCAUSKAS M, Galetta S
    Editors' note: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:103.
    PubMed     Text format    


  56. NONNEKES J, Bloem BR
    Deliberate gait scissoring to overcome freezing of gait in Parkinson disease.
    Neurology. 2018;91:97.
    PubMed     Text format    


    June 2018
  57. HACKER ML, DeLong MR, Turchan M, Heusinkveld LE, et al
    Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease.
    Neurology. 2018 Jun 29. pii: WNL.0000000000005903.
    PubMed     Text format     Abstract available


  58. CORVOL JC, Artaud F, Cormier-Dequaire F, Rascol O, et al
    Longitudinal analysis of impulse control disorders in Parkinson disease.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005816.
    PubMed     Text format     Abstract available


  59. DE PABLO-FERNANDEZ E, Goldacre R, Pakpoor J, Noyce AJ, et al
    Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2018 Jun 13. pii: WNL.0000000000005771.
    PubMed     Text format     Abstract available


    May 2018
  60. CHEN H
    Author response: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:941.
    PubMed     Text format    


  61. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Reader response: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:940.
    PubMed     Text format    


  62. ALCAUSKAS M, Galetta S
    Editors' note: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:940.
    PubMed     Text format    


  63. BOOT E, Butcher NJ, Udow S, Marras C, et al
    Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.
    Neurology. 2018 May 11. pii: WNL.0000000000005660.
    PubMed     Text format     Abstract available


  64. GROSS A, Racette BA, Camacho-Soto A, Dube U, et al
    Use of medical care biases associations between Parkinson disease and other medical conditions.
    Neurology. 2018 May 9. pii: WNL.0000000000005678.
    PubMed     Text format     Abstract available


  65. PALMA JA, Mano T
    Central or peripheral autonomic dysfunction in Parkinson disease: Does it matter?
    Neurology. 2018 May 4. pii: WNL.0000000000005624.
    PubMed     Text format    


    April 2018
  66. FERREIRA JJ, Lees AJ, Poewe W, Rascol O, et al
    Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.
    Neurology. 2018 Apr 25. pii: WNL.0000000000005557.
    PubMed     Text format     Abstract available


  67. FULLARD ME, Willis AW
    Author response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:813.
    PubMed     Text format    


  68. BRYANT MS, Protas EJ
    Reader response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:812.
    PubMed     Text format    


  69. KARAM C, Galetta S
    Editors' note: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:812.
    PubMed     Text format    


  70. GARDNER RC, Byers AL, Barnes DE, Li Y, et al
    Mild TBI and risk of Parkinson disease: A Chronic Effects of Neurotrauma Consortium Study.
    Neurology. 2018 Apr 18. pii: WNL.0000000000005522.
    PubMed     Text format     Abstract available


  71. ROOS E, Grotta A, Yang F, Bellocco R, et al
    Body mass index, sitting time, and risk of Parkinson disease.
    Neurology. 2018;90:e1413-e1417.
    PubMed     Text format     Abstract available


  72. KIM IY, O'Reilly EJ, Hughes KC, Gao X, et al
    Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts.
    Neurology. 2018 Apr 11. pii: WNL.0000000000005473.
    PubMed     Text format     Abstract available


  73. PAGANO G, Polychronis S, Wilson H, Giordano B, et al
    Diabetes mellitus and Parkinson disease.
    Neurology. 2018 Apr 6. pii: WNL.0000000000005475.
    PubMed     Text format     Abstract available


  74. DAS RR, Unger MM
    Diabetes and Parkinson disease: A sweet spot?
    Neurology. 2018 Apr 6. pii: WNL.0000000000005470.
    PubMed     Text format    


  75. BARRETT MJ, Blair JC, Sperling SA, Smolkin ME, et al
    Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005421.
    PubMed     Text format     Abstract available


  76. KOO BB, Chow CA, Shah DR, Khan FH, et al
    Demoralization in Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005425.
    PubMed     Text format     Abstract available


  77. BOHNEN NI, Teipel SJ
    Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005408.
    PubMed     Text format    


    March 2018
  78. BOLLAND MJ, Avenell A, Gamble G, Grey A, et al
    Reader response: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to
    Neurology. 2018;90:627-628.
    PubMed     Text format    


  79. KARAM C, Galetta S
    Editors' note: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to p
    Neurology. 2018;90:627.
    PubMed     Text format    


  80. ROY HA, Aziz TZ, Fitzgerald JJ, Green AL, et al
    Beta oscillations and urinary voiding in Parkinson disease.
    Neurology. 2018 Mar 23. pii: WNL.0000000000005355.
    PubMed     Text format     Abstract available


  81. FRATTINI E, Monfrini E, Bitetto G, Ferrari B, et al
    Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss.
    Neurology. 2018;90:572-575.
    PubMed     Text format    


  82. BRODSKY M, Lahna D, Pollock J, Pettersson D, et al
    Nigrosome 1 absence in de novo Parkinson disease.
    Neurology. 2018;90:522-523.
    PubMed     Text format    


    February 2018
  83. DIRKX MF, Zach H, Bloem BR, Hallett M, et al
    The nature of postural tremor in Parkinson disease.
    Neurology. 2018 Feb 23. pii: WNL.0000000000005215.
    PubMed     Text format     Abstract available


  84. HASSAN A
    No handshake agreement on postural tremor subtypes in Parkinson disease?
    Neurology. 2018 Feb 23. pii: WNL.0000000000005199.
    PubMed     Text format    


  85. PILOTTO A, Premi E, Paola Caminiti S, Presotto L, et al
    Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
    Neurology. 2018 Feb 16. pii: WNL.0000000000005161.
    PubMed     Text format     Abstract available


  86. WEISS D, Massano J
    Approaching adaptive control in neurostimulation for Parkinson disease: Autopilot on.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005111.
    PubMed     Text format    


  87. ARLOTTI M, Marceglia S, Foffani G, Volkmann J, et al
    Eight-hours adaptive deep brain stimulation in patients with Parkinson disease.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005121.
    PubMed     Text format     Abstract available


  88. HONMA M, Masaoka Y, Kuroda T, Futamura A, et al
    Impairment of cross-modality of vision and olfaction in Parkinson disease.
    Neurology. 2018 Feb 7. pii: WNL.0000000000005110.
    PubMed     Text format     Abstract available


    January 2018
  89. MURATA M, Odawara T, Hasegawa K, Iiyama S, et al
    Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized, double-blind phase 2 study.
    Neurology. 2018 Jan 24. pii: WNL.0000000000005010.
    PubMed     Text format     Abstract available


  90. HERSHEY LA, Irwin DJ
    Zonisamide for DLB parkinsonism: An old drug used in a new context.
    Neurology. 2018 Jan 24. pii: WNL.0000000000005006.
    PubMed     Text format    


  91. LEE PC, Ahmed I, Loriot MA, Mulot C, et al
    Smoking and Parkinson disease: Evidence for gene-by-smoking interactions.
    Neurology. 2018 Jan 19. pii: WNL.0000000000004953.
    PubMed     Text format     Abstract available


  92. DAVIS JL, Kurek JA, Morgan JC, Sethi KD, et al
    Teaching Video NeuroImages: Oculogyric crisis in treated Parkinson disease.
    Neurology. 2018;90:e263.
    PubMed     Text format    


  93. MUNOZ DG, Fujioka S
    Caffeine and Parkinson disease: A possible diagnostic and pathogenic breakthrough.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004898.
    PubMed     Text format    


  94. FUJIMAKI M, Saiki S, Li Y, Kaga N, et al
    Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004888.
    PubMed     Text format     Abstract available


    December 2017
  95. BARTHEL C, Nonnekes J, van Helvert M, Haan R, et al
    The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2017 Dec 20. pii: WNL.0000000000004795.
    PubMed     Text format     Abstract available


  96. ROSSO AL, Bohnen NI, Launer LJ, Aizenstein HJ, et al
    Vascular and dopaminergic contributors to mild parkinsonian signs in older adults.
    Neurology. 2017 Dec 15. pii: WNL.0000000000004842.
    PubMed     Text format     Abstract available


  97. MELE B, Holroyd-Leduc J, Smith EE, Pringsheim T, et al
    Detecting anxiety in individuals with Parkinson disease: A systematic review.
    Neurology. 2017 Dec 6. pii: WNL.0000000000004771.
    PubMed     Text format     Abstract available


  98. FERRER P, Montoya J, Garcia Ruiz PJ
    Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2017;89:e272-e273.
    PubMed     Text format    


  99. BROCKMANN K, Lerche S, Dilger SS, Stirnkorb JG, et al
    SNPs in Abeta clearance proteins: Lower CSF Abeta1-42 levels and earlier onset of dementia in PD.
    Neurology. 2017;89:2335-2340.
    PubMed     Text format     Abstract available


  100. DAHODWALA N, Shah K, He Y, Wu SS, et al
    Sex disparities in access to caregiving in Parkinson disease.
    Neurology. 2017 Dec 1. pii: WNL.0000000000004764.
    PubMed     Text format     Abstract available


    November 2017
  101. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Author response: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed     Text format    


  102. GUARALDI P, Poda R, Calandra-Buonaura G, Solieri L, et al
    Letter re: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed     Text format    


  103. DODEL R
    beta-Amyloid pathology and Parkinson disease.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004756.
    PubMed     Text format    


  104. WHITWELL JL, Weigand SD, Duffy JR, Clark HM, et al
    Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech.
    Neurology. 2017 Nov 1. pii: 10.1212/WNL.0000000000004685.
    PubMed     Text format     Abstract available


    October 2017
  105. CUMMING K, Macleod AD, Myint PK, Counsell CE, et al
    Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2017 Oct 27. pii: 10.1212/WNL.0000000000004691.
    PubMed     Text format     Abstract available


  106. MOLLENHAUER B, Caspell-Garcia CJ, Coffey CS, Taylor P, et al
    Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004609.
    PubMed     Text format     Abstract available


  107. UC EY, Rizzo M, O'Shea AMJ, Anderson SW, et al
    Longitudinal decline of driving safety in Parkinson disease.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004629.
    PubMed     Text format     Abstract available


  108. TABUAS-PEREIRA M, Santana I, Santo GC
    Clinical Reasoning: A 55-year-old man with rapidly progressive dementia and parkinsonism.
    Neurology. 2017;89:e182-e187.
    PubMed     Text format    


  109. BRODSKY MA, Anderson S, Murchison C, Seier M, et al
    Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004630.
    PubMed     Text format     Abstract available


  110. AZIZ TZ, Hariz M
    To sleep or not to sleep during deep brain stimulation surgery for Parkinson disease?
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004635.
    PubMed     Text format    


    September 2017
  111. LEEHEY M, Luo S, Sharma S, Wills AA, et al
    Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004572.
    PubMed     Text format     Abstract available


  112. HEDERA P, Davis TL
    Can lifestyle modification slow progression of Parkinson disease?
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004580.
    PubMed     Text format    


  113. POSTUMA RB, Anang J, Pelletier A, Joseph L, et al
    Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): A randomized trial.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004568.
    PubMed     Text format     Abstract available


  114. MOREAU C, Barton BR, Devos D
    Virtually reducing fall risk in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004581.
    PubMed     Text format    


  115. MAIDAN I, Rosenberg-Katz K, Jacob Y, Giladi N, et al
    Disparate effects of training on brain activation in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004576.
    PubMed     Text format     Abstract available


  116. THORMANN A, Sorensen PS, Koch-Henriksen N, Laursen B, et al
    Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.
    Neurology. 2017 Sep 20. pii: 10.1212/WNL.0000000000004508.
    PubMed     Text format     Abstract available


  117. SHAMIR R, Klein C, Amar D, Vollstedt EJ, et al
    Analysis of blood-based gene expression in idiopathic Parkinson disease.
    Neurology. 2017 Sep 15. pii: 10.1212/WNL.0000000000004516.
    PubMed     Text format     Abstract available


  118. LECLAIR-VISONNEAU L, Clairembault T, Coron E, Le Dily S, et al
    REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease.
    Neurology. 2017 Sep 8. pii: 10.1212/WNL.0000000000004496.
    PubMed     Text format     Abstract available


  119. BOWMAN GL
    Biomarkers for early detection of Parkinson disease: A scent of consistency with olfactory dysfunction.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004383.
    PubMed     Text format    


  120. CHEN H, Shrestha S, Huang X, Jain S, et al
    Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004382.
    PubMed     Text format     Abstract available


  121. SEARLES NIELSEN S, Warden MN, Camacho-Soto A, Willis AW, et al
    A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2017 Sep 1. pii: 10.1212/WNL.0000000000004536.
    PubMed     Text format     Abstract available


    August 2017
  122. FULLARD ME, Thibault DP, Hill A, Fox J, et al
    Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004355.
    PubMed     Text format     Abstract available


  123. NOLANO M, Provitera V, Manganelli F, Iodice R, et al
    Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients.
    Neurology. 2017;89:776-784.
    PubMed     Text format     Abstract available


  124. SHPRECHER DR, Majersik JJ
    The virtual house call: A 21st-century innovation in the care of patients with Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004366.
    PubMed     Text format    


  125. BECK CA, Beran DB, Biglan KM, Boyd CM, et al
    National randomized controlled trial of virtual house calls for Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004357.
    PubMed     Text format     Abstract available


  126. VERHAGEN METMAN L, Espay AJ
    Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease.
    Neurology. 2017;89:e83-e84.
    PubMed     Text format    


  127. CURY RG, Fraix V, Castrioto A, Perez Fernandez MA, et al
    Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia.
    Neurology. 2017 Aug 2. pii: 10.1212/WNL.0000000000004295.
    PubMed     Text format     Abstract available


    July 2017
  128. REGENSBURGER M, Turk M, Pagenstecher A, Schroder R, et al
    VCP-related multisystem proteinopathy presenting as early-onset Parkinson disease.
    Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004240.
    PubMed     Text format    


  129. IRANZO A, Stefani A, Serradell M, Marti MJ, et al
    Characterization of patients with longstanding idiopathic REM sleep behavior disorder.
    Neurology. 2017;89:242-248.
    PubMed     Text format     Abstract available


  130. JACOVA C, Factor SA
    Phosphodiesterase 4: Rethinking cognition in Parkinson disease.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004221.
    PubMed     Text format    


  131. NICCOLINI F, Wilson H, Pagano G, Coello C, et al
    Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004201.
    PubMed     Text format     Abstract available


  132. SIERRA M, Martinez-Rodriguez I, Sanchez-Juan P, Gonzalez-Aramburu I, et al
    Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004185.
    PubMed     Text format     Abstract available


  133. CILIA R, Laguna J, Cassani E, Cereda E, et al
    Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004175.
    PubMed     Text format     Abstract available



  134. Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017;89:107.
    PubMed     Text format    


    June 2017
  135. HUGHES KC, Gao X, Kim IY, Wang M, et al
    Intake of dairy foods and risk of Parkinson disease.
    Neurology. 2017 Jun 8. pii: 10.1212/WNL.0000000000004057.
    PubMed     Text format     Abstract available


  136. RAJPUT AH, Rajput ML, Ferguson LW, Rajput A, et al
    Baseline motor findings and Parkinson disease prognostic subtypes.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004078.
    PubMed     Text format     Abstract available


    May 2017
  137. MARKOVIC V, Agosta F, Canu E, Inuggi A, et al
    Role of habenula and amygdala dysfunction in Parkinson disease patients with punding.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004012.
    PubMed     Text format     Abstract available


  138. STOCCHI F, Rascol O, Hauser RA, Huyck S, et al
    Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004003.
    PubMed     Text format     Abstract available


    April 2017
  139. LIU B, Fang F, Pedersen NL, Tillander A, et al
    Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study.
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003961.
    PubMed     Text format     Abstract available


  140. BORGHAMMER P, Hamani C
    Preventing Parkinson disease by vagotomy: Fact or fiction?
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003969.
    PubMed     Text format    


    March 2017
  141. PAKPOOR J, Noyce A, Goldacre R, Selkihova M, et al
    Viral hepatitis and Parkinson disease: A national record-linkage study.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003848.
    PubMed     Text format     Abstract available


  142. BENITO-LEON J
    Viral hepatitis and the risk of Parkinson disease.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003853.
    PubMed     Text format    


  143. ROCHESTER L, Galna B, Lord S, Yarnall AJ, et al
    Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017 Mar 22. pii: 10.1212/WNL.0000000000003840.
    PubMed     Text format     Abstract available


  144. SINGER W, Berini SE, Sandroni P, Fealey RD, et al
    Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
    Neurology. 2017;88:1129-1136.
    PubMed     Text format     Abstract available


  145. NONNEKES J, Janssen S, Bloem BR
    Superficial brain stimulation to overcome freezing of gait in Parkinson disease.
    Neurology. 2017 Mar 15. pii: 10.1212/WNL.0000000000003859.
    PubMed     Text format    


  146. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
    Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
    PubMed     Text format     Abstract available


    February 2017
  147. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed     Text format    


  148. BOHNEN NI, Muller M
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed     Text format    


  149. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919-920.
    PubMed     Text format    


  150. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919.
    PubMed     Text format    


  151. GOLDMAN JG, Bledsoe IO, Merkitch D, Dinh V, et al
    Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.
    Neurology. 2017 Feb 24. pii: 10.1212/WNL.0000000000003764.
    PubMed     Text format     Abstract available


  152. MERY VP, Gros P, Lafontaine AL, Robinson A, et al
    Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.
    Neurology. 2017 Feb 22. pii: 10.1212/WNL.0000000000003738.
    PubMed     Text format     Abstract available


  153. LEWITT PA, Li J, Lu M, Guo L, et al
    Metabolomic biomarkers as strong correlates of Parkinson disease progression.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003663.
    PubMed     Text format     Abstract available


  154. ALVES G, Bonanni L
    Neurofilament light: A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003699.
    PubMed     Text format    


  155. HANSSON O, Janelidze S, Hall S, Magdalinou N, et al
    Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003680.
    PubMed     Text format     Abstract available


    January 2017
  156. EWENCZYK C, Mesmoudi S, Gallea C, Welter ML, et al
    Antisaccades in Parkinson disease: A new marker of postural control?
    Neurology. 2017 Jan 27. pii: 10.1212/WNL.0000000000003658.
    PubMed     Text format     Abstract available


  157. PEDERSEN KF, Larsen JP, Tysnes OB, Alves G, et al
    Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Neurology. 2017 Jan 20. pii: 10.1212/WNL.0000000000003634.
    PubMed     Text format     Abstract available


  158. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    PubMed     Text format     Abstract available


  159. KUBU CS, Cooper SE, Machado A, Frazier T, et al
    Insights gleaned by measuring patients' stated goals for DBS: More than tremor.
    Neurology. 2017;88:124-130.
    PubMed     Text format     Abstract available


    December 2016
  160. RACETTE BA, Searles Nielsen S, Criswell SR, Sheppard L, et al
    Dose-dependent progression of parkinsonism in manganese-exposed welders.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003533.
    PubMed     Text format     Abstract available


  161. RATNER MH, Fitzgerald E
    Understanding of the role of manganese in parkinsonism and Parkinson disease.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003543.
    PubMed     Text format    


  162. THOLFSEN LK, Larsen JP, Schulz J, Tysnes OB, et al
    Changes in insomnia subtypes in early Parkinson disease.
    Neurology. 2016 Dec 16. pii: 10.1212/WNL.0000000000003540.
    PubMed     Text format     Abstract available


    November 2016
  163. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003452.
    PubMed     Text format     Abstract available


  164. BOYLAN LS, Messinis L
    Orthostatic hypotension, cognition, and Parkinson disease: Dumbing down by standing up.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003468.
    PubMed     Text format    


  165. MANO T, Britton Z, Britton T
    Anatomo-functional basis of nonmotor symptoms in Parkinson disease.
    Neurology. 2016 Nov 16. pii: 10.1212/WNL.0000000000003443.
    PubMed     Text format    


  166. PYATIGORSKAYA N, Mongin M, Valabregue R, Yahia-Cherif L, et al
    Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease.
    Neurology. 2016 Nov 11. pii: 10.1212/WNL.0000000000003426.
    PubMed     Text format     Abstract available


  167. PAGANO G, Molloy S, Bain PG, Rabiner EA, et al
    Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003396.
    PubMed     Text format     Abstract available


    October 2016
  168. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    PubMed     Text format     Abstract available


  169. BRYS M, Fox MD, Agarwal S, Biagioni M, et al
    Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003279.
    PubMed     Text format     Abstract available


    September 2016
  170. UMEMOTO G, Fujioka S, Yanamoto S, Fukae J, et al
    A case of sudden deterioration in Parkinson disease.
    Neurology. 2016;87:1422.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: